Plain-English translation of NCT04801589 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Children in the ICU who need help breathing often receive sedation medications to keep them calm and comfortable. This study compares , a newer sedation drug, with , a medication doctors have used for many years. Researchers want to see if helps children wake up faster, spend less time in the hospital, and have fewer problems with thinking and memory after they recover.
Recent research shows that the standard sedation medication may increase the risk of delirium (serious confusion) and long-term brain problems in children. Adult studies suggest the new treatment causes less delirium and helps patients recover faster, but this hasn't been thoroughly tested in young children yet.
You likely qualify if…
You likely don't qualify if…
Your child will receive either or through an IV line while in the ICU on a breathing machine—the doctor will adjust the dose to keep your child calm and comfortable. You and the medical team won't know which medication your child is receiving (this is called a "blind" study). Your child will be monitored continuously with heart monitors and other standard ICU equipment, and the study team will track how long your child needs the breathing machine, any signs of confusion, and how your child's thinking and memory develop after leaving the hospital.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States